Michael Weening - 09 Feb 2023 Form 4 Insider Report for CALIX, INC (CALX)

Role: President & CEO
Signature: /s/ Tom Gemetti as Attorney-in-Fact for Michael Weening
Issuer symbol: CALX
Transactions as of: 09 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 10 Feb 2023, 17:59:42 UTC
Previous filing: 28 Nov 2022
Next filing: 16 Feb 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CALX	Common Stock	Award	$0	+100,000		$0.000000	100,000	09 Feb 2023	Common Stock	100,000	$55.96	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 10, 2022, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 9, 2023, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 100% of the grant had been achieved, resulting in a nonqualified stock option award of 100,000 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 10, 2023; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 10, 2023.

Content

On February 10, 2022, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 9, 2023, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 100% of the grant had been achieved, resulting in a nonqualified stock option award of 100,000 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 10, 2023; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 10, 2023.